Shanghai Ayk Biotechnology Co., Ltd
Dealing with challenges
Development of immune adjuvants and tumor vaccines
We have rich experience in complex glycochemistry and industrialization. Currently, three new tumor vaccines are under development, and multiple innovative vaccine adjuvant molecules are being industrializde.

Core R&D Team

AYKBIO was founded by multiple chemical biology overseas returnees and well-known domestic experts.

微信截图_20240519121430.png   Read More

Research Achievements

The scale of the main varieties has met the dosage of one million doses of vaccine/batch.

微信截图_20240519121430.png   Read More

Service Online

Email：ayk@aykbio.com

Phone：+86-21-68403318

微信截图_20240519121430.png   Read More

EMPOEERMENT INNOVATE VALUE
Join us and achieve the future together
Ankang continuously introduces outstanding talents to gather strength, fully leverage the leading role of talents, and promote enterprise innovation.